The collection require sponsors of any drug, biologic or device marketing application to certify to the absence of clinical investigators and/or disclose those financial interests as required, when covered clinical studies are submitted to FDA in support of product marketing.
The latest form for Financial Disclosure by Clinical Investigators expires 2022-04-30 and can be found here.
Document Name |
---|
Form |
Form |
Supporting Statement A |
Approved without change |
Extension without change of a currently approved collection | 2022-03-31 | |
Approved without change |
Extension without change of a currently approved collection | 2019-03-14 | |
Approved with change |
Extension without change of a currently approved collection | 2015-11-06 | |
Approved with change |
Extension without change of a currently approved collection | 2012-07-27 | |
Approved with change |
Extension without change of a currently approved collection | 2009-04-28 | |
Approved without change |
Extension without change of a currently approved collection | 2006-02-16 | |
Approved without change |
Reinstatement with change of a previously approved collection | 2003-01-02 | |
Withdrawn |
Reinstatement without change of a previously approved collection | 2002-07-08 | |
Approved without change |
New collection (Request for a new OMB Control Number) | 1999-01-15 |
Federal Enterprise Architecture: Health - Consumer Health and Safety
Form 3454 | FDA Form 3454 | Fillable Fileable | Form |
Review document collections for all forms, instructions, and supporting documents - including paper/printable forms.